Age-Related Macular Degeneration

In this video, Manjot K. Gill, MD, professor of ophthalmology and medical education at Northwestern Feinberg School of Medicine, discusses rising rates of AMD and what clinicians need to consider to accommodate a growing patient population.

Byooviz, a biosimilar referencing Lucentis, has been launched in the United States and will be commercially available on July 1, according to a press release.

Outlook Therapeutics is withdrawing its biologics license application for ONS-5010 for the treatment of wet age-related macular degeneration after the FDA requested more information, according to a press release.

A dietary supplement that includes the antioxidants lutein and zeaxanthin helped slow progression of age-related macular degeneration.

Stem cell therapy still has many hurdles to clear before becoming a viable therapeutic option for age-related macular degeneration, but it may have the potential to transform treatment in the future.

In this edition, diet, genetics and family history play role in AMD progression; omega-3 fatty acids may improve vision in dry AMD; long-term dopamine treatment may delay onset of diabetic retinopathy; and more.

FORT LAUDERDALE, Fla. — Susvimo was noninferior to monthly ranibizumab and provided comparable vision and controlled retinal thickness through 96 weeks, according to data from the Archway trial.

FORT LAUDERDALE, Fla. — A senolytic therapy represents a novel approach to treating diabetic macular edema and wet age-related macular degeneration, according to a speaker at the Retina World Congress.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Nancy Lurker, president and CEO of EyePoint Pharmaceuticals, discusses the latest update on EYP-1901.

DENVER — High-dose aflibercept maintained visual acuity in patients with neovascular age-related macular degeneration at 48 months, according to a study presented at the Association for Research in Vision and Ophthalmology meeting.